HK1073478A1 - Expec-specific proteins, genes encoding them and uses thereof - Google Patents

Expec-specific proteins, genes encoding them and uses thereof

Info

Publication number
HK1073478A1
HK1073478A1 HK05104637.6A HK05104637A HK1073478A1 HK 1073478 A1 HK1073478 A1 HK 1073478A1 HK 05104637 A HK05104637 A HK 05104637A HK 1073478 A1 HK1073478 A1 HK 1073478A1
Authority
HK
Hong Kong
Prior art keywords
polypeptides
expec
genes encoding
specific proteins
conserved
Prior art date
Application number
HK05104637.6A
Other languages
English (en)
Inventor
Sonia Escaich
Original Assignee
Mutabilis S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mutabilis S A filed Critical Mutabilis S A
Publication of HK1073478A1 publication Critical patent/HK1073478A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK05104637.6A 2002-03-06 2005-06-01 Expec-specific proteins, genes encoding them and uses thereof HK1073478A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02290556A EP1342784A1 (en) 2002-03-06 2002-03-06 ExPEC-specific proteins, genes encoding them and uses thereof
PCT/EP2003/002925 WO2003074553A2 (en) 2002-03-06 2003-03-06 Expec-specific proteins, genes encoding them and uses thereof

Publications (1)

Publication Number Publication Date
HK1073478A1 true HK1073478A1 (en) 2005-10-07

Family

ID=27741246

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104637.6A HK1073478A1 (en) 2002-03-06 2005-06-01 Expec-specific proteins, genes encoding them and uses thereof

Country Status (9)

Country Link
US (2) US20060188514A1 (xx)
EP (3) EP1342784A1 (xx)
JP (2) JP2006502696A (xx)
AT (1) ATE466086T1 (xx)
AU (2) AU2003227537A1 (xx)
CA (1) CA2478277A1 (xx)
DE (1) DE60332324D1 (xx)
HK (1) HK1073478A1 (xx)
WO (1) WO2003074553A2 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148324A1 (en) * 2001-02-02 2003-08-07 Edouard Bingen Polynucleotides which are of nature B2/D+ A- and which are isolated from E. coli, and biological uses of these polynucleotides and of their polypeptides
EP1570856A3 (en) 2004-02-26 2005-10-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) A vaccine composition comprising an immunoadjuvant compound consisting of a RHO GTPase family activator
EP1580195A1 (en) * 2004-03-26 2005-09-28 Mutabilis SA Compositions of polypeptides specific to pathogenic ExPEC E. coli strains and their use as vaccines and in immunotherapy
NZ580974A (en) * 2005-02-18 2011-05-27 Novartis Vaccines & Diagnostic Immunogens from uropathogenic escherichia coli
LT2351772T (lt) 2005-02-18 2016-10-10 Glaxosmithkline Biologicals Sa Baltymai ir nukleorūgštys iš su meningitu/sepsiu susijusių escherichia coli
WO2008020330A2 (en) * 2006-08-16 2008-02-21 Novartis Ag Immunogens from uropathogenic escherichia coli
ITMI20090946A1 (it) 2009-05-28 2010-11-29 Novartis Ag Espressione di proteine ricombinanti
AU2010272243A1 (en) 2009-07-16 2012-03-08 Novartis Ag Detoxified Escherichia coli immunogens
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
ES2076895B1 (es) * 1994-02-04 1996-08-16 Ind Farma Especial Fimbrias-adhesinas de tipo 1 y p aisladas de nuevas cepas de e. coli, procedimiento para su obtencion y aplicaciones.
JPH11506424A (ja) * 1995-03-24 1999-06-08 オフィディアン ファーマシューティカルズ インコーポレーテッド ベロ毒素産生大腸菌に対する治療
US6365723B1 (en) * 1998-12-04 2002-04-02 Wisconsin Alumni Research Foundation Sequences of E. coli O157
US20030148324A1 (en) * 2001-02-02 2003-08-07 Edouard Bingen Polynucleotides which are of nature B2/D+ A- and which are isolated from E. coli, and biological uses of these polynucleotides and of their polypeptides
WO2001066572A2 (en) * 2000-03-10 2001-09-13 Institut National De La Sante Et De La Recherche Medicale (I.N.S.E.R.M.) Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof

Also Published As

Publication number Publication date
WO2003074553A3 (en) 2004-03-25
DE60332324D1 (de) 2010-06-10
EP1481062B1 (en) 2010-04-28
US20060188514A1 (en) 2006-08-24
AU2003227537A1 (en) 2003-09-16
US20100260789A1 (en) 2010-10-14
JP2010189411A (ja) 2010-09-02
EP2253707A2 (en) 2010-11-24
JP2006502696A (ja) 2006-01-26
EP1481062A2 (en) 2004-12-01
AU2010201045A1 (en) 2010-04-08
EP2253707A3 (en) 2011-03-02
EP1342784A1 (en) 2003-09-10
CA2478277A1 (en) 2003-09-12
WO2003074553A2 (en) 2003-09-12
AU2003227537A2 (en) 2003-09-16
ATE466086T1 (de) 2010-05-15

Similar Documents

Publication Publication Date Title
HK1073478A1 (en) Expec-specific proteins, genes encoding them and uses thereof
AU6160201A (en) Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
EP1539228A4 (en) NEW COMPOSITION AND METHOD FOR THE TREATMENT OF IMMUNE DISEASES
AU5810201A (en) Immunogenic polypeptides encoded by mage minigenes and uses thereof
GB0014907D0 (en) Antigenic polypeptides
MX9606013A (es) Lacasas purificadas de myceliophthora y acidos nucleicos que codifican para las mismas.
SI1317479T1 (sl) Postopki in sestavki za bolezni, povezane z amiloidozo
MXPA03008715A (es) Reduccion de la inmunogenicidad de proteinas de fusion.
HK1120556A1 (en) Neurotrophic factors
ATE334998T1 (de) Verfahren zur herstellung cyclischer peptide
ATE461937T1 (de) Pili von haemophilus influenzae typ iv
WO2001077291A3 (en) Polynucleotides encoding novel secreted proteins
DK1290160T3 (da) Humane Pellino-polypeptider
EP1613345A4 (en) COMPOSITIONS AND METHODS WITH THE RESPIRATORY SYNCYTIAL VIRUS SUB-GROUP B STAMM 9320
DK0892054T3 (da) Clostridium perfringens-vaccine
WO2001077288A3 (en) Polynucleotides encoding novel secreted proteins
WO2002018576A3 (en) Compositions and methods relating to lung specific genes
WO2002012468A3 (en) 2,5-dkg permeases
GB9727512D0 (en) Fuzzy genes and their application in molecular adjuvants
ATE503003T1 (de) Verfahren zur herstellung rekombinanter polypeptide
WO2003048304A3 (en) ALLOIOCOCCUS OTITIDIS OPEN READING FRAMES (ORFs) ENCODING POLYPEPTIDE ANTIGENS, IMMUNOGENIC COMPOSITIONS AND USES THEREOF
WO2001077290A3 (en) Polynucleotides encoding novel secreted proteins
ATE451461T1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
DE60328114D1 (de) Kautschukverstärktes vinylharz, verfahren zur herstellung von kautschukverstärktem vinylharz und kautschukverstärktes vinylharz enthaltende zusammensetzung
ATE329032T1 (de) Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140306